GLP-1 Weight-Loss Drug Use Rose Among College Students
Young adults are increasingly using medications like Wegovy and tirzepatide, raising questions about safety and reproductive health.
Updated on Sept. 20, 2026 in Weight Loss
Live Poll
Is the pressure to look thin causing unnecessary use of medical weight-loss drugs?
College students are increasingly using GLP-1 weight-loss medications for cosmetic purposes, including during sorority recruitment. While the drugs have grown in popularity among young adults, experts express concern over the non-medical use of these treatments.
Why it matters
The pressure to meet specific thin beauty ideals has fueled a trend of using GLP-1 agonists to achieve rapid weight loss on college campuses. This behavior carries significant health risks, particularly because these drugs can interact with hormonal birth control and require discontinuation before pregnancy.
A 2024 JAMA analysis identified 162,439 young adults using GLP-1 medications in 2023, while a 2025 Monitoring the Future survey found 2% of students in grades 8, 10, and 12 used prescription GLP-1s and another 2% used non-prescription versions.
The players
JAMA
A peer-reviewed medical journal that provides clinical research and public health data.
The details
GLP-1 medications function by mimicking hormones that regulate appetite and blood sugar levels, which can lead to significant weight loss. However, these drugs also pose risks to reproductive health, as tirzepatide can reduce the efficacy of oral hormonal contraceptives, and labeling specifically advises patients to stop semaglutide at least two months before a planned pregnancy. The rise in compounded, non-prescription versions further complicates safety by bypassing standard regulatory oversight.
Timeline
2023 saw 162,439 young adults receive GLP-1 prescriptions.
A JAMA analysis of this usage was published in 2024.
Data from the Monitoring the Future survey was released in 2025.
Health Landscape
This trend aligns with data from the Monitoring the Future survey regarding the evolution of non-prescribed substance use among youth. It highlights a departure from clinical obesity treatment toward the cosmetic misuse of potent metabolic therapies.
If you are considering a weight-loss medication, it is essential to discuss the risks to reproductive health and potential drug interactions with your physician. Be aware that non-prescription or compounded weight-loss products lack the safety testing and oversight of FDA-approved medications.
The takeaway
The cosmetic use of GLP-1 medications among young adults carries risks that often go unconsidered in social media-driven weight-loss competitions. Always consult a medical professional to ensure your approach to weight management is safe, monitored, and appropriate for your specific health history.
Further reading
For more information on the clinical use and safety of these treatments, visit Weight Loss.
Live Poll
Is the pressure to look thin causing unnecessary use of medical weight-loss drugs?
